Back
Albemarle Vs. Corcept Therapeutics Industry Stock Comparison
Sell
43
ALB
Albemarle
Last Price:
100.21
Seasonality Move:
7.58%
Buy
67
CORT
Corcept Therapeutics
Last Price:
45.75
Seasonality Move:
7.94%
Sell
43
Albemarle (ALB)
is a Sell
Is Albemarle a Buy, Sell or Hold?
- The current Albemarle [ALB] share price is $104.47. The Score for ALB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- ALB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $44.66. The Score for CORT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $44.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
ALB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.5 | Buy |
| Relative Strength Index (14 RSI): | 68.52 | Buy |
| Chaikin Money Flow: | 3281697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.72 - 95.9) | Buy |
| Bollinger Bands (100): | (82.51 - 111.55) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.58 | Buy |
| Relative Strength Index (14 RSI): | 65.14 | Buy |
| Chaikin Money Flow: | -550738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.02 - 44.84) | Buy |
| Bollinger Bands (100): | (29.85 - 39.13) | Buy |
ALB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.9 | Buy |
| 20-day SMA: | 91.3 | Buy |
| 50-day SMA: | 87.23 | Buy |
| 200-day SMA: | 111.03 | Sell |
| 8-day EMA: | 97.16 | Buy |
| 20-day EMA: | 92.75 | Buy |
| 50-day EMA: | 91.39 | Buy |
| 200-day EMA: | 112.8 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.16 | Sell |
| 20-day SMA: | 41.94 | Buy |
| 50-day SMA: | 37.68 | Buy |
| 200-day SMA: | 29.47 | Buy |
| 8-day EMA: | 44.73 | Sell |
| 20-day EMA: | 42.36 | Buy |
| 50-day EMA: | 38.6 | Buy |
| 200-day EMA: | 31.78 | Buy |
Albemarle Earnings Growth & ALB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.99 per share, a decrease next quarter of $0.00 per share, a decrease this year of $21.16 per share, and an increase next year of $3.29 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.73 per share.
Albemarle Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||